search
confirm
cancel

中文

1

Product Center

Product Center

Process development and optimization of pharmaceutical intermediates and APIs

Process development and optimization of pharmaceutical intermediates and APIs

Copyright: Nantong Nuotai Biomedical Technology Co., Ltd.

Isavuconazole

Broad-spectrum triazole antifungal; treatment of invasive mucormycosis and aspergillosis in adults

Copyright: Nantong Nuotai Biomedical Technology Co., Ltd.

Entecavir

Treatment of chronic adult hepatitis B

Copyright: Nantong Nuotai Biomedical Technology Co., Ltd.

Ixitecan

DNA topoisomerase I (topoisomerase I) inhibitors for cancer research

Copyright: Nantong Nuotai Biomedical Technology Co., Ltd.

Fondaparinux Sodium

Anticoagulant drugs for major lower extremity orthopedic surgery to prevent venous thromboembolic events

About Us

·Company news ·Industry news ·Frontline information

Nantong Nuotai Biomedical Technology Co., Ltd. was established in Nantong Haimen Science and Technology Park in March 2015. The company has 60 employees, 20 R&D teams, and 90% of them have bachelor degree or above. The company has always been market-oriented and innovation-driven; it is committed to providing pharmaceutical companies with innovative chemical services throughout the entire industry chain, including: research and development of innovative drugs, process development and optimization of key pharmaceutical intermediates and APIs; high-end pharmaceutical intermediates commercial production and custom synthesis services.
     Nuotai will uphold the concept of innovation, devote itself to drug innovation, always insist on enhancing the value of brands, creating differences with innovation, and winning competition with cost to meet the needs of the market. "Core" business philosophy, serve new and old customers at home and abroad, and make Nuotai a trustworthy partner for domestic and foreign customers!

Copyright: Nantong Nuotai Biomedical Technology Co., Ltd.
Copyright: Nantong Nuotai Biomedical Technology Co., Ltd.

About Us

·Company news ·Industry news ·Frontline information

Nantong Nuotai Biomedical Technology Co., Ltd. was established in Nantong Haimen Science and Technology Park in March 2015. The company has 60 employees, 20 R&D teams, and 90% of them have bachelor degree or above. The company has always been market-oriented and innovation-driven; it is committed to providing pharmaceutical companies with innovative chemical services throughout the entire industry chain, including: research and development of innovative drugs, process development and optimization of key pharmaceutical intermediates and APIs; high-end pharmaceutical intermediates commercial production and custom synthesis services.
     Nuotai will uphold the concept of innovation, devote itself to drug innovation, always insist on enhancing the value of brands, creating differences with innovation, and winning competition with cost to meet the needs of the market. "Core" business philosophy, serve new and old customers at home and abroad, and make Nuotai a trustworthy partner for domestic and foreign customers!

Research and production base

In 2019, it will be located in a provincial chemical park in Shandong Province, and will be invested in Jinan, Shandong to establish Shandong Elite Biomedical Technology Co., Ltd.

The workshop construction will be completed in 2020.

In 2021, the trial production will be completed and it will be officially put into production.

Copyright: Nantong Nuotai Biomedical Technology Co., Ltd.

Anhydrous, oxygen-free, hydrogenated

Copyright: Nantong Nuotai Biomedical Technology Co., Ltd.

High temperature and high pressure, ultra-low temperature

Copyright: Nantong Nuotai Biomedical Technology Co., Ltd.

Optimization and commercial production of difficult chemical processes

Copyright: Nantong Nuotai Biomedical Technology Co., Ltd.
Copyright: Nantong Nuotai Biomedical Technology Co., Ltd.
Copyright: Nantong Nuotai Biomedical Technology Co., Ltd.
Copyright: Nantong Nuotai Biomedical Technology Co., Ltd.
Copyright: Nantong Nuotai Biomedical Technology Co., Ltd.
Copyright: Nantong Nuotai Biomedical Technology Co., Ltd.

Research and production base

In 2019, it will be located in a provincial chemical park in Shandong Province, and will be invested in Jinan, Shandong to establish Shandong Elite Biomedical Technology Co., Ltd.

The workshop construction will be completed in 2020.

In 2021, the trial production will be completed and it will be officially put into production.

Copyright: Nantong Nuotai Biomedical Technology Co., Ltd.

Anhydrous, oxygen-free, hydrogenated

Copyright: Nantong Nuotai Biomedical Technology Co., Ltd.

High temperature and high pressure, ultra-low temperature

Copyright: Nantong Nuotai Biomedical Technology Co., Ltd.

Optimization and commercial production of difficult chemical processes

Copyright: Nantong Nuotai Biomedical Technology Co., Ltd.
Copyright: Nantong Nuotai Biomedical Technology Co., Ltd.
Copyright: Nantong Nuotai Biomedical Technology Co., Ltd.
Copyright: Nantong Nuotai Biomedical Technology Co., Ltd.
Copyright: Nantong Nuotai Biomedical Technology Co., Ltd.
Copyright: Nantong Nuotai Biomedical Technology Co., Ltd.

News Center

2020

08 18

The company has a research and development center of more than 3,000 square meters, which is good at optimization and commercial production of difficult chemical processes such as cyanidation, azide, ultra-low temperature, anhydrous and oxygen-free, hydrogenation, high temperature and high pressure, and fluorination.

2019

08 16

The company has a research and development center of more than 3,000 square meters, which is good at optimization and commercial production of difficult chemical processes such as cyanidation, azide, ultra-low temperature, anhydrous and oxygen-free, hydrogenation, high temperature and high pressure, and fluorination.

2018

06 24

The company has a research and development center of more than 3,000 square meters, which is good at optimization and commercial production of difficult chemical processes such as cyanidation, azide, ultra-low temperature, anhydrous and oxygen-free, hydrogenation, high temperature and high pressure, and fluorination.

2017

03 30

The company has a research and development center of more than 3,000 square meters, which is good at optimization and commercial production of difficult chemical processes such as cyanidation, azide, ultra-low temperature, anhydrous and oxygen-free, hydrogenation, high temperature and high pressure, and fluorination.

Copyright: Nantong Nuotai Biomedical Technology Co., Ltd.

BY:XINNET